Patents by Inventor Els Robanus Maandag

Els Robanus Maandag has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040107452
    Abstract: The present invention provides novel methods for modifying the genome of an animal cell which typically comprise the steps of: constructing a DNA molecule in which desired sequence modifications are contained in a segment of DNA (a “targeting DNA”) that is substantially isogenic with a DNA in the cell genome (a “target DNA”); introducing the targeting DNA construct into the cell (e.g., by microinjection, electroporation, transfection, or calcium phosphate precipitation); and selecting cells in which the desired sequence modifications have been introduced into the genome via homologous recombination.
    Type: Application
    Filed: November 24, 2003
    Publication date: June 3, 2004
    Applicant: GENPHARM INTERNATIONAL, INC.
    Inventors: Anton Berns, Els Robanus Maandag, Hein Te Riele
  • Patent number: 6653113
    Abstract: The present invention provides novel methods for modifying the genome of an animal cell which typically comprise the steps of: constructing a DNA molecule in which desired sequence modifications are contained in a segment of DNA (a “targeting DNA”) that is substantially isogenic with a DNA in the cell genome (a “target DNA”); introducing the targeting DNA construct into the cell (e.g., by microinjection, electroporation, transfection, or calcium phosphate precipitation); and selecting cells in which the desired sequence modifications have been introduced into the genome via homologous recombination.
    Type: Grant
    Filed: February 19, 1999
    Date of Patent: November 25, 2003
    Assignee: Genpharm International, Inc.
    Inventors: Anton Berns, Els Robanus Maandag, Hein te Riele
  • Patent number: 5789215
    Abstract: The present invention provides novel methods for modifying the genome of an animal cell which typically comprise the steps of: constructing a DNA molecule in which desired sequence modifications are contained in a segment of DNA (a "targeting DNA") that is substantially isogenic with a DNA in the cell genome (a."target DNA"); introducing the targeting DNA construct into the cell (e.g., by microinjection, electroporation, transfection, or calcium phosphate precipitation); and selecting cells in which the desired sequence modifications have been introduced into the genome via homologous recombination.
    Type: Grant
    Filed: August 7, 1997
    Date of Patent: August 4, 1998
    Assignee: GenPharm International
    Inventors: Anton Berns, Els Robanus Maandag, Hein te Riele